Universal influenza virus vaccines: need for clinical trials (Q42248242)

19 October 2017

title

Universal influenza virus vaccines: need for clinical trials (English)

1 reference

19 October 2017

1

1 reference

19 October 2017

2

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 January 2014

1 reference

19 October 2017

1 reference

19 October 2017

volume

15

1 reference

19 October 2017

issue

1

1 reference

19 October 2017

page(s)

3-5

1 reference

Human infection with a novel avian-origin influenza A (H7N9) virus

19 October 2017

cites work

1 reference

Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans

21 January 2018

1 reference

Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

21 January 2018

1 reference

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination

21 January 2018

1 reference

Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies

21 January 2018

1 reference

Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.

21 January 2018

1 reference

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP M1, in humans

21 January 2018

1 reference

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

21 January 2018

1 reference

Highly Conserved Protective Epitopes on Influenza B Viruses

21 January 2018

1 reference

Antibody recognition of a highly conserved influenza virus epitope

21 January 2018

1 reference

A highly conserved neutralizing epitope on group 2 influenza A viruses

21 January 2018

1 reference

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

21 January 2018

1 reference

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

21 January 2018

1 reference

Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies

21 January 2018

1 reference

H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice

21 January 2018

1 reference

Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice

21 January 2018

1 reference

Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses

21 January 2018

1 reference

Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine

21 January 2018

1 reference

Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus

21 January 2018

1 reference

Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease

21 January 2018

1 reference

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada

21 January 2018

1 reference

Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial

21 January 2018

1 reference

Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel

21 January 2018

1 reference

Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City

21 January 2018

1 reference

No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.

21 January 2018

1 reference

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.

21 January 2018

1 reference

1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans

21 January 2018

1 reference

Why do influenza virus subtypes die out? A hypothesis

21 January 2018

1 reference

Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24352315

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24352315

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24352315

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NI.2761

1 reference

19 October 2017

1 reference